Genetic variation in metabolic phenotypes: study designs and applications
Tóm tắt
Từ khóa
Tài liệu tham khảo
Garrod, A. E. The incidence of alkaptonuria a study in chemical individuality. Lancet 2, 1616–1620 (1902).
Mootha, V. K. & Hirschhorn, J. N. Inborn variation in metabolism. Nature Genet. 42, 97–98 (2010). This comment provides an independant view on the potential of genetic studies with metabolomics.
Garrod, A. E. Inborn Factors in Disease (Oxford Univ. Press, 1931). Archibald Garrod noted more than 80 years ago that “diathesis is nothing else but chemical individuality”.
Link, E. et al. SLCO1B1 variants and statin-induced myopathy—a genomewide study. N. Engl. J. Med. 359, 789–799 (2008).
Dumont, J. et al. FADS1 genetic variability interacts with dietary α-linolenic acid intake to affect serum non-HDL-cholesterol concentrations in European adolescents. J. Nutr. 141, 1247–1253 (2011).
Lu, Y. et al. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL-cholesterol concentrations in the Doetinchem Cohort Study. Am. J. Clin. Nutr. 92, 258–265 (2010).
Krug, S. et al. The dynamic range of the human metabolome revealed by challenges. FASEB J. 26, 2607–2619 (2012). This paper reports a series of controlled physiological challenges that may be used in future GWASs with metabolic traits.
Nicholson, G. et al. Human metabolic profiles are stably controlled by genetic and environmental variation. Mol. Syst. Biol. 7, 525 (2011). This paper addresses essential questions about the heritability of metabolic traits.
Kettunen, J. et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nature Genet. 44, 269–276 (2012). This paper reports a large GWAS with NMR-derived metabolic traits.
Suhre, K. et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 5, e13953 (2010). This paper reports a pilot study on three different metabolomics platforms and provides practical insights into the possibilities and pitfalls of high-throughput metabolomics experiments.
Mittelstrass, K. et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 7, e1002215 (2011).
Nicholson, G. et al. A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genet. 7, e1002270 (2011).
Suhre, K. et al. A genome-wide association study of metabolic traits in human urine. Nature Genet. 43, 565–569 (2011).
Suhre, K. et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477, 54–60 (2011). This paper reports 37 loci of human metabolic individuality and provides examples for a wide range of biomedical and pharmaceutical applications.
Illig, T. et al. A genome-wide perspective of genetic variation in human metabolism. Nature Genet. 42, 137–141 (2010).
Kastenmuller, G. Romisch-Margl, W., Wagele, B., Altmaier, E. & Suhre, K. metaP-server: a web-based metabolomics data analysis tool. J. Biomed. Biotechnol. 2011, 839862 (2011).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
Abecasis, G. R., Cherny, S. S., Cookson, W. O. & Cardon, L. R. Merlin—rapid analysis of dense genetic maps using sparse gene flow trees. Nature Genet. 30, 97–101 (2002).
Marchini, J. & Howie, B. Genotype imputation for genome-wide association studies. Nature Rev. Genet. 11, 499–511 (2010).
Gieger, C. et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 4, e1000282 (2008). This paper reports the first GWAS with metabolic traits and with ratios between metabolite concentrations.
Tanaka, T. et al. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI study. PLoS Genet. 5, e1000338 (2009).
Hicks, A. A. et al. Genetic determinants of circulating sphingolipid concentrations in European populations. PLoS Genet. 5, e1000672 (2009).
Demirkan, A. et al. Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. PLoS Genet. 8, e1002490 (2012).
Wishart, D. S. et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37, D603–D610 (2009).
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40, D109–D114 (2012).
Altmaier, E. et al. Bioinformatics analysis of targeted metabolomics--uncovering old and new tales of diabetic mice under medication. Endocrinology 149, 3478–3489 (2008).
Petersen, A. K. et al. On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies. BMC Bioinformatics 13, 120 (2012). This paper provides a statistical underpinning to using ratios between metabolite concentrations in association studies.
Borenstein, M., Hedges, L. V., Higgins, J. P. T. & Rothstein, H. R. Introduction to Meta-Analysis (Wiley, 2009).
Krumiesk, J. et al. Mining the unknown: A systems approach to metabolite identification combining genetic and metabolic information. PLoS Genet. (in the press).
Cornelis, M. C. et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet. 7, e1002033 (2011).
Zhang, A., Sun, H., Wang, P., Han, Y. & Wang, X. Recent and potential developments of biofluid analyses in metabolomics. J. Proteomics 75, 1079–1088 (2011).
Yu, Z. et al. Differences between human plasma and serum metabolite profiles. PLoS ONE 6, e21230 (2011).
Tukiainen, T. et al. Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci. Hum. Mol. Genet. 21, 1444–1455 (2012).
Inouye, M. et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol. Syst. Biol. 6, 441 (2010).
Kottgen, A. et al. New loci associated with kidney function and chronic kidney disease. Nature Genet. 42, 376–384 (2010).
Suhre, K. et al. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing. J. Biomol. Screen 16, 467–475 (2011).
Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genet. 42, 105–116 (2010).
Sanna, S. et al. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum. Mol. Genet. 18, 2711–2718 (2009).
Johnson, A. D. et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum. Mol. Genet. 18, 2700–2710 (2009).
Kolz, M. et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 5, e1000504 (2009).
Zhai, G. et al. Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS Genet. 7, e1002025 (2011).
Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).
Kathiresan, S. et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nature Genet. 40, 189–197 (2008).
Willer, C. J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nature Genet. 40, 161–169 (2008).
Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nature Genet. 41, 56–65 (2009).
Kronenberg, F. in Genetics Meets Metabolomics: from Experiment to Systems Biology (ed. Suhre, K.) 255–264 (Springer, 2012).
The Wellcome Trust Case Control Conortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature Genet. 42, 1118–1125 (2010).
Kato, N. et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nature Genet. 43, 531–538 (2011).
Rothman, N. et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nature Genet. 42, 978–984 (2010).
Chambers, J. C. et al. Genetic loci influencing kidney function and chronic kidney disease. Nature Genet. 42, 373–375 (2010).
Wallace, C. et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am. J. Hum. Genet. 82, 139–149 (2008).
Li, S. et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 3, e194 (2007).
Doring, A. et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nature Genet. 40, 430–436 (2008).
Ferreira, M. A. & Purcell, S. M. A multivariate test of association. Bioinformatics 25, 132–133 (2009).
Ried, J. S. et al. PSEA: phenotype set enrichment analysis—a new method for analysis of multiple phenotypes. Genet. Epidemiol. 36, 244–252 (2012).
Raychaudhuri, S. et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 5, e1000534 (2009).
Krumsiek, J., Suhre, K., Illig, T., Adamski, J. & Theis, F. J. Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Syst. Biol. 5, 21 (2011). This paper introduces partial correlation networks to high-throughput metabolomics studies that may be used in a systems biology approach to GWAS with metabolic traits.